GREENWICH, Conn., March 27, 2025 /PRNewswire/ -- Addtronics, LLC ("Addtronics"), a consolidator of high-quality, niche automation technology and solution providers innovating...
NEW YORK, March 27, 2025 /PRNewswire/ -- Healthee, a leader in AI-driven health benefits navigation, is expanding its employer-focused value...
CARY, N.C., March 27, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical...
ROYAL OAK, Mich., March 27, 2025 /PRNewswire/ -- Independent pharmacies across the country are saving thousands on prescription drugs, thanks...
-Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer-...
Studies to assess efficacy, safety, user experience, and nasal residence time as Company prepares for regulatory path forward Raanana, Israel,...
Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU) Strategic alternatives...
Dear Shareholders, TAMPA, FL, March 27, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (“Wellgistics Health”), This time last...
Chetan Pujara, Ph.D Chief Research & Development Officer, SpyGlass Pharma Dr. Pujara brings extensive industry experience to guide late-stage development...
COPENHAGEN, Denmark, March 27, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
BOULDER, Colo., March 26, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced...
A global collaboration agreement has been signed for the development and commercialization of a Granzyme B-targeted Positron Emission Tomography (PET)...
Ellen Scipta and Chris Cowen join the organization as CFO and CCO, respectively, while Todd Martensen transitions from CCO to...
SAN FRANCISCO, March 26, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced enhancements to its randomization...
Pheno.AI's Human Phenotype Project (HPP) to Catalyze the Future of AI-Driven Health with Japanese Cohort TOKYO, March 26, 2025 /PRNewswire/...
OLLIE integrates with Pleio's GoodStart program and supports pharmaceutical companies in earlier identification and understanding of patient sentiment and confidence...
Presidential lecture to be delivered by Robert Langer at Rice followed by RBL LLC launch event with keynote presentation by Robert...
NEW YORK and PARIS, March 26, 2025 /PRNewswire/ -- Rarecells Inc., a pioneering company in liquid biopsy technology, is pleased...
New tools will calculate the ROI of using digital endpoints in clinical trials, empowering greater innovation in research BOSTON, March...
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc....